# Erythropoietin in Premature Infants to Prevent Encephalopathy

> **NCT02550054** · PHASE2 · TERMINATED · sponsor: **Children's Hospital of Fudan University** · enrollment: 58 (actual)

## Conditions studied

- Premature Infant

## Interventions

- **DRUG:** Epo
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT02550054
- **Lead sponsor:** Children's Hospital of Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-09-08
- **Primary completion:** 2016-12-30
- **Final completion:** 2016-12-30
- **Target enrollment:** 58 (ACTUAL)
- **Why stopped:** The study was concluded as planned upon reaching its predetermined endpoint, which included the completion of data collection and achievement of the necessary sample size for statistical significance.
- **Last updated:** 2023-12-29

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02550054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02550054, "Erythropoietin in Premature Infants to Prevent Encephalopathy". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02550054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*